Aspermont EV/Sales
Cos'è EV/Sales di Aspermont?
EV/Sales di Aspermont Limited è 2.35
Qual è la definizione di EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales di aziende nel Communication Services settore su ASX rispetto a Aspermont
Cosa fa Aspermont?
Aspermont Limited provides media services to resource industries in Australia, Asia, Europe, the United States, and internationally. It also provides publications, researches, and events, as well as other publications in partnership with external agencies across various trade sectors, including mining, investment, agriculture, and energy. In addition, the company offers online publications that provide news and information directly on desktops, tablets, and smart phones, as well as print publications through tablet and mobile apps. Further, it organizes events and conferences. Aspermont Limited was incorporated in 1961 and is based in Perth, Australia.
Aziende con ev/sales simili a Aspermont
- Biodesix Inc ha EV/Sales di 2.35
- Peeks Social ha EV/Sales di 2.35
- American Express ha EV/Sales di 2.35
- Kelt Exploration ha EV/Sales di 2.35
- National Steel and Agro Industries ha EV/Sales di 2.35
- Raminfo ha EV/Sales di 2.35
- Aspermont ha EV/Sales di 2.35
- Kraft Heinz Co ha EV/Sales di 2.35
- Datametrex AI ha EV/Sales di 2.35
- Fusion Antibodies plc ha EV/Sales di 2.35
- Solara Active Pharma Sciences ha EV/Sales di 2.35
- Kaman ha EV/Sales di 2.35
- GlaxoSmithKline Plc ha EV/Sales di 2.35